← Live Studies
MARITIME-SWITCH: Switching GLP-1 medicines
Looks at efficacy, safety and tolerability when adults who have lost weight on a weekly GLP-1 medicine switch to investigational maridebart cafraglutide.
Who it's for
- Age 18+
- Already using a stable weekly GLP-1 medicine with prior weight loss
- Diabetes excluded
Full eligibility rules apply. The study team decides who can take part.
Where it runs
9 research locations in Arizona, California and Hawaii.
Arizona
- Arizona Clinical TrialsChandler, AZ
- Epic Medical Research - Sun CitySun City, AZ
- Clinical Research Institute of Arizona LLCSun City West, AZ
California
- Desert Oasis Healthcare Medical GroupPalm Springs, CA
- Inland Empire Liver FoundationRialto, CA
- Peninsula Research AssociatesRolling Hills Estates, CA
- Apex Clinical ResearchSan Diego, CA
- Southern California Clinical ResearchSanta Ana, CA
Hawaii
- Mel A. Ona, M.D., IncorporatedKapolei, HI
Site recruitment may change. The official record lists every location, including outside these states.
Interested in this study?
Ask us about it, or refer a patient. Taking part is voluntary, and the study team decides who can join.

